Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells
1997

Effects of Manumycin and KT7595 on Cancer Cell Growth

publication Evidence: moderate

Author Information

Author(s): T Nagase, S Kawata, S Tamura, Y Matsuda, Y Inui, E Yamasaki, H Ishiguro, T Ito, J Miyagawa, H Mitsui, K Yamamoto, M Kinoshita, Y Matsuzawa

Primary Institution: Osaka University Medical School

Hypothesis

Do manumycin and KT7595 inhibit cellular proliferation by blocking Ras farnesylation without affecting nuclear lamin function?

Conclusion

Manumycin and KT7595 effectively inhibit Ras farnesylation and cell growth in certain human tumor cell lines without disturbing the farnesylation and localization of nuclear lamins.

Supporting Evidence

  • Manumycin and KT7595 inhibited DNA synthesis and cellular proliferation in LoVo cells by blocking Ras farnesylation.
  • Neither drug affected the farnesylation and localization of nuclear lamins.
  • LoVo cells showed a significant response to both drugs, while KATO III cells were resistant.

Takeaway

This study shows that two drugs can stop cancer cells from growing by blocking a specific process in the cells, but they don't affect another important part of the cells.

Methodology

The study tested the effects of manumycin and KT7595 on various human cancer cell lines, measuring DNA synthesis and cell growth.

Limitations

The study only examined a limited number of cell lines and did not explore the effects on all Ras proteins.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication